
Migraine Treatment Zavegepant Shows No Meaningful Impact on Oral Contraceptive Exposure
In a phase 1 study published in Headache, investigators reported that multiple-dose intranasal zavegepant (Zavzpret; Pfizer), a calcitonin gene-related peptide receptor (CGRP) antagonist approved by the FDA for acute migraine treatment, did not …